Your browser is unsupported
We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.
The Institute for Tuberculosis Research (ITR), located at the University of Illinois at Chicago, is a drug discovery research facility working on the development of new drugs to combat an old, but still evolving global public health threat. The ITR is unique in that it brings an industrial model of drug discovery into an academic environment. In Chicago we have assembled all of the necessary components - medicinal chemistry, natural products chemistry, microbiology, drug metabolism, pharmacokinetics and toxicology – under one roof to maximize efficiency and communication. In addition to in-house discovery projects, we also collaborate with many public and private sector institutions around the world to facilitate their efforts towards the same goal.
Located in Chicago, our members come from China, France, Germany, India, Iran, Korea, Poland, Spain and the U.S. Our group includes primary faculty, affiliate faculty, adjunct faculty, BS, MS and PhD staff scientists, and administrative staff. We occupy 5,500 sq. ft. of labs and offices in the College of Pharmacy at the University of Illinois at Chicago.
Our research is supported by the Global Alliance for TB Drug Development, the National Institutes of Health, Chicago Biomedical Consortium, fee-for-service arrangements from industry, and a patent royalty stream. Our annual budget consists of over 1.5 million dollars.